{"id":46,"date":"2025-10-13T19:54:18","date_gmt":"2025-10-13T17:54:18","guid":{"rendered":"https:\/\/europa-peptide.com\/?post_type=product&p=46"},"modified":"2026-05-23T16:37:31","modified_gmt":"2026-05-23T14:37:31","slug":"retatrutid","status":"publish","type":"product","link":"https:\/\/europa-peptide.com\/de\/shop\/retatrutide\/","title":{"rendered":"Retatrutid"},"content":{"rendered":"

Retatrutid - Multi-Rezeptor-Peptid f\u00fcr Stoffwechsel- und Gewichtsmanagement<\/strong><\/p>\n

Zusammensetzung: <\/strong>Retatrutid (lyophilisiertes Peptidpulver)
Kategorie:<\/strong> Peptid
Form:<\/strong> Fl\u00e4schchen mit gefriergetrocknetem Pulver
Verwaltung:<\/strong> Subkutane Injektion nach Rekonstitution mit bakteriostatischem Wasser<\/p>\n

\n

Was ist Retatrutid?<\/h3>\n

Retatrutid ist ein fortschrittliches, lang wirkendes dreifach agonistisches Peptid<\/strong> die gleichzeitig die GLP-1 (Glucagon-Like Peptide-1)<\/strong>, GIP (Glukose-abh\u00e4ngiges insulinotropes Polypeptid)<\/strong>und Glucagon-Rezeptoren<\/strong>.
Es geh\u00f6rt zu einer neuen Generation von Peptide aus der Stoffwechselforschung<\/strong> konzipiert f\u00fcr den Energieaufwand zu erh\u00f6hen<\/strong>, den Appetit z\u00fcgeln<\/strong>und Verbesserung des Glukose- und Fettstoffwechsels<\/strong>.<\/p>\n

Durch die gleichzeitige Aktivierung mehrerer Stoffwechselwege hat Retatrutid ein bemerkenswertes Potenzial bei pr\u00e4klinische und klinische Studien<\/strong> untersuchen. Fettleibigkeit, Insulinresistenz,<\/strong> und Stoffwechselst\u00f6rungen<\/strong>.<\/p>\n

\u27a1\ufe0f Ideal f\u00fcr Energiebilanz, Gewichtsregulierung,<\/strong> und Stoffwechselmodulation auf Peptidbasis.<\/strong><\/p>\n

\n

Wichtige Forschungsergebnisse<\/h3>\n

Dreifache Rezeptoraktivierung:<\/strong> Gleichzeitige Stimulation von GLP-1, GIP,<\/strong> und Glucagon-Rezeptoren<\/strong> f\u00fcr eine verbesserte Stoffwechseleffizienz.<\/p>\n

Appetit- und Energieregulierung:<\/strong> Beeinflusst zentrale Mechanismen der Appetitkontrolle<\/strong> und f\u00f6rdert Kalorienverbrauch<\/strong>.<\/p>\n

Glukose- und Fettstoffwechsel:<\/strong> Unterst\u00fctzt verbesserte Insulinempfindlichkeit, Glukose-Hom\u00f6ostase,<\/strong> und Fettoxidation<\/strong>.<\/p>\n

K\u00f6rperzusammensetzung:<\/strong> Untersucht auf sein Potenzial zur K\u00f6rperfett reduzieren<\/strong> w\u00e4hrend Erhaltung der mageren Masse<\/strong>.<\/p>\n

\n

Dosierung und Anwendung<\/h3>\n

Rekonstituieren mit bakteriostatisches Wasser<\/strong> vor dem Gebrauch.<\/p>\n

Typischer Forschungsbereich: 0,25-1,0 mg pro Anwendung<\/strong>subkutan (je nach Studiendesign).<\/p>\n

H\u00e4ufigkeit: Variabel, h\u00e4ufig 1-2 Mal pro Woche<\/strong> in langfristigen Stoffwechselstudien.<\/p>\n

Die rekonstituierte L\u00f6sung aufbewahren gek\u00fchlt<\/strong> und Verwendung innerhalb 30 Tage<\/strong>.<\/p>\n

\n

Anweisungen zur Lagerung<\/h3>\n
    \n
  • \n

    Speichern unter 2-8 \u00b0C (36-46 \u00b0F)<\/strong><\/p>\n<\/li>\n

  • \n

    Sch\u00fctzen Sie sich vor Licht und Feuchtigkeit<\/strong><\/p>\n<\/li>\n

  • \n

    Nicht einfrieren<\/strong><\/p>\n<\/li>\n

  • \n

    Vermeiden Sie Temperaturschwankungen<\/p>\n<\/li>\n<\/ul>\n

    \n

    Warum Retatrutid w\u00e4hlen?<\/h3>\n

    Retatrutid ist eines der die fortschrittlichsten Multi-Agonisten-Peptide<\/strong> die derzeit untersucht werden.
    Durch seine synergistische Aktivierung von GLP-1-, GIP- und Glucagon-Rezeptoren<\/strong>bietet sie einzigartige Einblicke in die hormonelle Regulierung des Energiehaushalts, des Fettstoffwechsels und der Appetitkontrolle<\/strong>.<\/p>\n

    Retatrutid bestellen <\/strong>\u00a0und erforschen sein Potenzial in der die n\u00e4chste Generation der Stoffwechsel- und Gewichtsmanagementforschung.<\/strong><\/p>","protected":false},"excerpt":{"rendered":"

    Retatrutide \u2013 Multi-Receptor Peptide for Metabolic & Weight Management Composition: Retatrutide (lyophilized peptide powder)Category: PeptideForm: Vial with freeze-dried powderAdministration: Subcutaneous injection after reconstitution with bacteriostatic water What is Retatrutide? Retatrutide is an advanced, long-acting triple agonist peptide that simultaneously activates the GLP-1 (Glucagon-Like Peptide-1), GIP (Glucose-Dependent Insulinotropic Polypeptide), and Glucagon receptors.It belongs to a new generation of metabolic research peptides designed to increase energy expenditure, regulate appetite, and improve glucose and lipid metabolism. Through the simultaneous activation of multiple metabolic pathways, Retatrutide has shown remarkable potential in preclinical and clinical studies investigating obesity, insulin resistance, and metabolic disorders. \u27a1\ufe0f Ideal for energy balance, weight regulation, and peptide-based metabolic modulation. Key Research Findings Triple Receptor Activation: Simultaneous stimulation of GLP-1, GIP, and Glucagon receptors for enhanced metabolic efficiency. Appetite & Energy Regulation: Influences central mechanisms of appetite control and promotes caloric expenditure. Glucose & Lipid Metabolism: Supports improved insulin sensitivity, glucose homeostasis, and fat oxidation. Body Composition: Studied for its potential to reduce body fat while preserving lean mass. Dosage & Application Reconstitute with bacteriostatic water before use. Typical research range: 0.25\u20131.0 mg per application, subcutaneously (depending on study design). Frequency: Variable, often 1\u20132 times per week in long-term metabolic studies. Store the reconstituted solution refrigerated and use within 30 days. Storage Instructions Store at 2\u20138 \u00b0C (36\u201346 \u00b0F) Protect from light and moisture Do not freeze Avoid temperature fluctuations Why Choose Retatrutide? Retatrutide is one of the most advanced multi-agonist peptides currently under investigation.Through its synergistic activation of GLP-1, GIP, and Glucagon receptors, it provides unique insights into the hormonal regulation of energy balance, fat metabolism, and appetite control. Order Retatrutide \u00a0and explore its potential in the next generation of metabolic and weight management research.<\/p>","protected":false},"featured_media":59,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[17,24,25,27],"product_tag":[],"class_list":["post-46","product","type-product","status-publish","has-post-thumbnail","product_cat-all-products","product_cat-glp-1andmultiagonist","product_cat-metabolismandweightmanagement","product_cat-peptidesandresearchdrugs","entry","has-media","first","instock","sale","purchasable","product-type-variable"],"acf":[],"aioseo_notices":[],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/europa-peptide.com\/de\/wp-json\/wp\/v2\/product\/46","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/europa-peptide.com\/de\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/europa-peptide.com\/de\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/europa-peptide.com\/de\/wp-json\/wp\/v2\/comments?post=46"}],"version-history":[{"count":3,"href":"https:\/\/europa-peptide.com\/de\/wp-json\/wp\/v2\/product\/46\/revisions"}],"predecessor-version":[{"id":28952,"href":"https:\/\/europa-peptide.com\/de\/wp-json\/wp\/v2\/product\/46\/revisions\/28952"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/europa-peptide.com\/de\/wp-json\/wp\/v2\/media\/59"}],"wp:attachment":[{"href":"https:\/\/europa-peptide.com\/de\/wp-json\/wp\/v2\/media?parent=46"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/europa-peptide.com\/de\/wp-json\/wp\/v2\/product_brand?post=46"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/europa-peptide.com\/de\/wp-json\/wp\/v2\/product_cat?post=46"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/europa-peptide.com\/de\/wp-json\/wp\/v2\/product_tag?post=46"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}